Sign in or register to access exclusive content on this site
REGISTER

Home | Central nervous system | Aromatic L-amino acid decarboxylase (AADC) deficiency | Congress activities | International Symposium on Paediatric Movement Disorders (ISPMD)

International Symposium on Paediatric Movement Disorders (ISPMD)

The International Symposium on Paediatric Movement Disorders (ISPMD) takes place every 2 years, to facilitate and strengthen scientific collaborations in this rapidly evolving field of pediatric medicine.

Please select the resource of interest below:

|
Congress
Topic
Type
Year
International Symposium on Paediatric Movement Disorders (ISPMD)
ISPMD 2024 poster: Pharmacodynamics of eladocagene exuparvovec and safety of the SmartFlow magnetic resonance-compatible ventricular cannula for administering eladocagene exuparvovec in paediatric participants
This poster, presented at ISPMD 2024, explores the administration of eladocagene exuparvovec using the SmartFlow magnetic resonance (MR)-compatible ventricular cannular in pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency
Eladocagene Exuparvovec is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC Therapeutics at pharmacovigilance@ptcbio.com.

Registration conditions differ internationally; always consult local prescribing information and/or Summary of Product Characteristics before prescribing any products.

MED-ALL-PTC-AADC-2500006 | September 2025

MED-ALL-AADC-2200032 | June 2025

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This website may include scientific information about investigational and unlicensed products not approved for use within your country. Please refer to local regulatory guidance for country-specific information

© 2025 PTC Therapeutics. All rights reserved | MED-ALL-CORP-2200029 | June 2025

This content is protected.

To view it please enter your email address below:

Register here to access the content on the site

MED-ALL-CORP-2200029 | June 2025

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.